Knight Therapeutics Inc., (TSX: GUD) ("Knight") a pan-American (ex-USA) specialty pharmaceutical company, announced today that its Brazilian affiliate, United ...

Q25 EPS of $2.92 versus $3.31 in 2Q24 2Q25 Net Income of $94.7 million versus $113.2 million in 2Q24 2Q25 Consolidated Operating income of $113.0 million versus ...

Brush up your history with the MCU's latest animated anthology miniseries, Eyes of Wakanda—which focuses on the members of ...